Eli Lilly loses patent lawsuit for Strattera

[Seeking Serenity]

Source: AP

INDIANAPOLIS – Eli Lilly & Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera.

The U.S. District Court for the District of New Jersey ruled against the company, saying its method-of-use patent for the drug is invalid.

The patent had been set to expire in May 2017.

The drugmaker said it plans to appeal the ruling, but noted that it now faces the prospects of potentially having to compete with a generic version of the drug.


Read more: http://news.yahoo.com/s/ap/20100813/ap_on_bi_ge/us_eli_lilly_patent_2

---

This is great news. Strattera is a wonderful medication for ADHD children, but it is very expensive, and if it is covered by insurance plans at all, it's usually on Tier 3 or something similar. A cheaper, geneneric form of this drug is badly needed.

[targetpractice]

1. I want another drug that has the cognitive benefits of Straterra, but...

...without the horrible side effects.

[Seeking Serenity]

2. Well, okay

I know that some children have side effects from Strattera, but I'd prefer a cheaper generic of that, than what it is now.